Lallemand Health Solutions new active member of Alliance Promotion Microbiote

Lallemand Health Solutions joins up to support the mission of the Alliance Promotion Microbiote, a newly formed association to place the microbiome…

Lallemand Steps in to Support COVAX-UNICEF Campaign with a $US 100,000 donation

Lallemand contributes to the unprecedented global COVID-19 vaccination campaign via the COVAX Facility with a $US 100,000 donation to UNICEF Canada. With…

Lafti® L10 gains innovative Canadian health claims as an antioxidant probiotic

Lallemand Health Solutions has gained new indications for its documented EXPERT’Biotic™ L. helveticus Lafti® L10 from Health Canada recognizing its antioxidant properties,…

An exclusive agreement that will bring direct benefits to probiotic consumers, worldwide

Lallemand Health Solutions and Aventus Innovations have signed a global agreement to grant Lallemand exclusive use of Aventus’ flagship technology, NutraJIT®, for…

The Rosell® Institute for Microbiome and Probiotics by Lallemand: Platinum sponsor of Having IMPACTT: Advancing Microbiome Research Symposium

As a platinum sponsor, The Rosell® Institute for Microbiome and Probiotics by Lallemand will join forces with the organizers to promote “Having…

Efficacy of a multi-strain probiotic formulation in pediatric populations: A comprehensive review of clinical studies

Lallemand Health Solutions’ Probiokid®, the world’s best-selling pediatric probiotic formulation, makes the scientific news with its most recent review: “Efficacy of a…

Mind, Mood & Microbes: International conference on Microbiota-Gut-Brain axis

As a co-founding partner of Mind, Mood & Microbes, Lallemand Health Solutions invites you to register to this third edition of the…

Lallemand Health Solutions’ Scientific Exchange 2021: Close to elucidating new mechanistic pathways for specific probiotics

On Friday, April 23 took place, virtually, the 11th edition of the Scientific Exchange (SciEx), organized by Thomas A. Tompkins, Ph.D., Research…

New scientific article published in Frontiers: Viral Infections, the Microbiome, and Probiotics

Lallemand Health Solutions’ R&D Director for Microbiome Program and Bioprocess and Galenic Center, Sylvie Binda, together with IPA colleagues have cowritten a…

Lallemand Health Solutions’ Research Director chosen for External Advisory Board at the University of Florida

Thomas A. Tompkins, Ph.D., Research Director at the Rosell® Institute from Microbiome and Probiotics by Lallemand, is proud to be joining the…